nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiographic and Clinical Outcomes after PCI for Stent-Thrombosis
|
Vinall, Maria |
|
2007 |
7 |
5 |
p. 16-16 |
artikel |
2 |
Drug-Eluting Stents: An Update
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 20-26 |
artikel |
3 |
Enoxaparin Continues to Show Clinical Benefit Vs Unfractionated Heparin for STEMI
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 11-11 |
artikel |
4 |
Heart Failure
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 4-18 |
artikel |
5 |
Immediate Angioplasty after Thrombolytic Therapy Can save Lives and Reduce Recurrent Heart Attacks in AMI Patients
|
Vinall, Maria |
|
2007 |
7 |
5 |
p. 12-13 |
artikel |
6 |
Lowering Blood Pressure in Patients with Type 2 Diabetes Significantly Reduces the Risk of Death from Diabetic Complications Even in Patients with Normal Blood Pressure
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 17-18 |
artikel |
7 |
Metabolic Syndrome Interventions
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 24-25 |
artikel |
8 |
New Frontiers in Cardiac Computed Tomography
|
Vinall, Phil |
|
2007 |
7 |
5 |
p. 19-26 |
artikel |
9 |
No Benefit Shown for Facilitated PCI
|
Vinall, Phil |
|
2007 |
7 |
5 |
p. 12-12 |
artikel |
10 |
Raising HDL: Is it a Good Idea?
|
Vinall, Phil |
|
2007 |
7 |
5 |
p. 8-18 |
artikel |
11 |
Selected Updates on ESC Guidelines
|
Vinall, Maria |
|
2007 |
7 |
5 |
p. 22-23 |
artikel |
12 |
STEMI: From Trials to Clinical Practice
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 25-26 |
artikel |
13 |
Study Supports Anti-Arrhythmic Effects of Ranolazine in Patients with Acute Coronary Syndrome
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 13-14 |
artikel |
14 |
Subgroup Analysis of BENEFiT Trial to Evaluate Effect of Bosentan for Patients with CTEPH
|
Vinall, Maria |
|
2007 |
7 |
5 |
p. 14-15 |
artikel |
15 |
The Role of Genetic Testing in Cardiomyopathy
|
Vinall, Maria |
|
2007 |
7 |
5 |
p. 7-8 |
artikel |
16 |
The Use of Drug-Eluting Stents in Patients with ST-Elevation Myocardial Infarction Increases Mortality Compared to Bare Metal Stenting at 2-Years
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 17-17 |
artikel |
17 |
3-Year Clinical Data Continue to Show Superiority of Sirolimus-Eluting versus Bare Metal Stents in STEMI Patients
|
Alexander, Lori |
|
2007 |
7 |
5 |
p. 10-11 |
artikel |
18 |
4-Year Follow-up Shows No Increased Mortality with Drug-Eluting Stents Compared to Bare Metal Stents in over 60,000 Patients
|
Vinall, Maria |
|
2007 |
7 |
5 |
p. 9-10 |
artikel |